巴利昔单抗
医学
他克莫司
肾小球疾病
移植
免疫抑制
肾移植
肾
泌尿科
肾功能
内科学
胃肠病学
肾小球肾炎
作者
Toshiaki Suzuki,Soichiro Okubo,Yohei Ikezumi,Mitsuhiro Ueno,Shinichi Nishi,Kazuhide Saito,Kouta Takahashi,Makoto Uchiyama
出处
期刊:Japanese Journal of Nephrology
日期:2004-01-01
卷期号:46 (4): 360-4
被引量:9
摘要
Collagenofibrotic glomerulopathy is a recently recognized entity that is characterized by massive accumulation of collagen fibrils in the mesangial and subendothelial areas, and an elevated serum level of procollagen III peptide (PIIIP). We report the first case of a collagenofibrotic glomerulopathy patient who received a kidney transplantation. She received the kidney transplantation at the age of 18 years and the post-operative course was uneventful with good renal function on immunosuppression, which consisted of methylprednisolone, tacrolimus and basiliximab. Although urinary protein was negative, the serum level of PIIIP gradually elevated which suggests new collagen production in the graft. These findings indicate that the recipient had a systemic factor that stimulated collagen production. To investigate the prognosis of collagenofibrotic glomerulopathy, we carried out a questionnaire survey on 14 patients at 9 hospitals. None of these patients had received a kidney transplantation. However, 7 already had end-stage renal failure. Ten years after diagnosis, the renal survival rate was 49%. This rate is lower than cited in previous reports.
科研通智能强力驱动
Strongly Powered by AbleSci AI